Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0360674466
Tue, 16.12.2025
Galenica AG
Galenica AG
/ Key word(s): Takeover
Galenica further expands online offering and acquires majority stake in Puravita 16.12.2025 / 13:55 CET/CEST
Press release
Galenica increases its investment in Puravita to 80% and further expands its digital presence.
In doing so, Galenica is expanding its online offering in the drugstore [ … ]
Mon, 10.11.2025
Galenica AG
Galenica AG
/ Key word(s): Bond
Galenica successfully places a bond of over CHF 250 million 10.11.2025 / 17:55 CET/CEST
Press release
Today, Galenica successfully placed a fixed rate bond of over CHF 250 million. The bond has a term of 7 years and an annual coupon of 1.08%. The proceeds from the transaction will be used to rep [ … ]
Thu, 23.10.2025
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.
Sales growth is driven by prescription drugs and dietary supplements.
Thanks to the acquisition of Labor Team, Galenica now expects sales growth of between 4% and 6% and an increase in EBIT1 of between 10% an [ … ]
Tue, 21.10.2025
Galenica AG
Galenica AG
/ Key word(s): Product Launch
Galenica strengthens basic care with new pharmacy concept 21.10.2025 / 07:55 CET/CEST
Press release
Pharmacies play a key role in healthcare.
Galenica is testing a new pharmacy concept with a focus on consultations and customer experience at the Amavita pharmacy in Zurich’s Glattzent [ … ]
Wed, 10.09.2025
Galenica AG
Galenica AG
/ Key word(s): Takeover
Launch of Galenica Diagnostics: Acquisition of Labor Team completed 10.09.2025 / 06:45 CET/CEST
Press release
Labor Team will become part of the Galenica network once the acquisition is complete.
The fourth-largest private laboratory in Switzerland will continue to operate under the Labor T [ … ]
Thu, 07.08.2025
Galenica AG
Galenica Group sales grew by 5.0% to CHF 1,995.4 million in the first half of 2025.
Adjusted EBIT1 increased by 10.9% to CHF 109.9 million – supported by positive one-time effects of CHF 5.4 million.
Galenica is therefore raising its EBIT guidance and now expects growth between 7% and 9% (previously growth between 4% and 6%).
Guidance for 2025 [ … ]
Wed, 02.07.2025
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
By acquiring the Labor Team Group, Galenica is adding a leading Swiss diagnostic service provider to its healthcare network.
The strategic acquisition will enable Galenica to further expand its offerings in the physicians segment.
This opens up the possibility of offering selected additiona [ … ]
Thu, 22.05.2025
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Sales growth of 4.7% to CHF 1,314.2 million
Strong growth in all key business areas
Guidance for 2025 confirmed – sales growth of 3-5% and EBIT1 growth of 4-6% expected
With a sales growth of 4.7% to CHF 1,314.2 million in the first four months, the Galenica Group made an excellent start t [ … ]
Thu, 10.04.2025
Galenica AG
Galenica AG
/ Key word(s): AGMEGM
Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors 10.04.2025 / 18:12 CET/CEST
Press release
All motions of the Board of Directors approved with broad consensus
Nadine Balkanyi-Nordmann elected as a new member of the Board of Directors
Divide [ … ]
Tue, 11.03.2025
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million. As a result, Galenica outperformed market growth and gained market share in all its main business areas.
Adjusted1 EBIT increased by 10.3% to CHF 211.0 [ … ]
